LL-37 (Cathelicidin) Dosage Guide
Complete guide to LL-37 (Cathelicidin) dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose per Injection
500 mcg – 1.6 mg
Frequency
Once per day
Route
topical
Cycle Length
2–4 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols vary widely.
Typical ranges
50-200mcg administered subcutaneously 2-3 times weekly.
Some protocols use higher doses for acute infections.
Administration Method
Subcutaneous injection. Can cause significant injection site reactions. Often used in conjunction with other immune-supporting protocols.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.20 ml
Syringe units (U-100): 20.0 units
Pre-filled with LL-37 (Cathelicidin) defaults. Adjust values as needed.
Side Effects to Monitor
Injection site pain and reactions are common. May cause flu-like symptoms, temporary fatigue, or immune activation responses.
Safety Considerations & Risks
May overstimulate immune system in autoimmune conditions. Limited human research data. Quality and purity concerns with research products.